Jansa U, Stein G, Günther K
Abteilung Nephrologie, Friedrich-Schiller-Universität Jena.
Z Gesamte Inn Med. 1991 Dec;46(17):642-7.
We retrospectively analysed the effects of a 12-month treatment with captopril (Tensiomin) in 46 patients. All of the patients had hypertension lasting for years (9 essential, 37 with chronic renal failure), 32 of them had proteinuria. Captopril was given in addition to, or in exchange for, other antihypertensive drugs. Under treatment with ACE-inhibitors, a small but significant decrease in diastolic blood pressure (0.4 torr/month) and in proteinuria (0.19 g/month) was seen (regression analysis). Discriminant analysis showed proteinuria and diastolic blood pressure to be the more modifiable, the younger the patients, the higher the proteinuria at the beginning and the longer the history of hypertension. Serum creatinine, blood urea nitrogen, serum protein and serum potassium did not change.
我们回顾性分析了46例患者接受卡托普利(开博通)12个月治疗的效果。所有患者均患有多年高血压(9例原发性高血压,37例慢性肾衰竭),其中32例有蛋白尿。卡托普利作为其他降压药物的补充或替代药物使用。在接受血管紧张素转换酶抑制剂治疗期间,舒张压(每月下降0.4托)和蛋白尿(每月下降0.19克)出现了轻微但显著的下降(回归分析)。判别分析表明,患者年龄越小、初始蛋白尿水平越高、高血压病史越长,蛋白尿和舒张压就越容易得到改善。血清肌酐、血尿素氮、血清蛋白和血钾均无变化。